Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Jazz_Pharmaceuticals
|
| gptkbp:acquisitionYear |
2005
|
| gptkbp:focus |
rare diseases
|
| gptkbp:founded |
1994
|
| gptkbp:headquartersLocation |
gptkb:Minnetonka,_Minnesota,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Orphan Medical, Inc.
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Xyrem
|
| gptkbp:status |
defunct
|
| gptkbp:stockSymbol |
ORPH
|
| gptkbp:bfsParent |
gptkb:Fomepizole
|
| gptkbp:bfsLayer |
6
|